Leftover Mounjaro in Your Pen: What's Normal and What to Check

A small amount of liquid visible after injection is by design: the KwikPen holds a manufacturing overfill and residual fluid in the needle pathway, this is not a missed dose.
A full, undisturbed dose window after pressing the button usually points to a technique or equipment issue rather than the pen being faulty.
Each Mounjaro KwikPen delivers one dose only; the remaining fluid after that dose should never be combined with another pen or injected a second time.
Needle length, injection speed and site choice all affect how much fluid appears to remain, changing the needle before each injection matters more than most people realise.

You've pressed the button, waited, and pulled the pen away — but there's still liquid visible in the KwikPen window. If you've spotted leftover Mounjaro in the pen after an injection, you're not alone; it's one of the questions our prescribers hear most weeks. The short answer is that a small amount of fluid remaining after a correctly administered dose is entirely normal and does not mean your dose was incomplete. The Mounjaro KwikPen is designed to hold a slight excess — what you see in the window is not medication you've missed; it's part of how the pen is engineered. That said, there are a few situations worth understanding, and tirzepatide as a weight-management medicine works best when doses are delivered consistently and correctly, so it's worth knowing what each scenario actually means.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding what the pen window is actually showing you

You've just injected, and there's still liquid in the window

Picture it: you've prepared your pen, found your site, pressed the button and held it for the full ten seconds as the instructions say. You pull the pen away and glance at the window. There's a sliver of liquid still visible. The instinct is to wonder whether the dose went in at all.

It did. The Mounjaro KwikPen is a multi-dose device (each pen contains four weekly doses) and Eli Lilly engineers each cartridge with a small overfill to ensure the correct volume reaches the needle tip every single time. What remains in the window after a properly completed injection is a combination of that overfill allowance and fluid that sits in the needle hub itself. According to the Mounjaro Summary of Product Characteristics on the eMC, the pen is calibrated to deliver the stated dose volume; residual liquid after use is expected and does not indicate an incomplete injection.

The most common misconception is that every drop of liquid in the cartridge must enter the body for the dose to count. It doesn't work that way. The pen's plunger moves a fixed, measured distance and no further. So long as you heard or felt the click, held the pen against the skin for the full ten seconds and saw the plunger move, your dose is almost certainly complete. Let that worry go.

Where it gets more interesting is when the window looks completely unchanged after pressing the button, that's a different situation and worth exploring below.

When the pen window barely moves: technique checks before assuming a fault

If the liquid level in the window looks virtually the same before and after you pressed the button, the dose may not have delivered fully. This is less common, but it does happen, and the cause is almost always technique or equipment rather than a defective pen.

First, check the needle. Mounjaro uses screw-on needles, and a needle that isn't attached tightly, or that was used for a previous injection, can block the flow entirely. Our guide to screw-on needles for Mounjaro walks through how to attach them correctly. A bent or blocked needle tip is often invisible to the eye but can stop the medication reaching the skin. Replacing the needle before every injection is not optional, it's the single most practical step for consistent delivery.

Second, the ten-second hold matters more than it sounds. Releasing the pen too quickly means the plunger hasn't completed its travel and some medication stays in the cartridge. Hold the pen firmly against the skin, button pressed, and count slowly to ten before removing it.

Third, skin folds and injection depth play a role. If the needle isn't fully inserted at a 90-degree angle, especially on thinner injection sites, some fluid can track back along the needle rather than disperse into tissue. Rotating between the abdomen, thigh and upper arm helps, as does gently pinching the skin if you're injecting on a leaner area.

If after checking all of this the window still isn't moving as expected, the NHS guidance on tirzepatide advises contacting your prescriber or pharmacist rather than attempting to re-inject. Don't try to use the same dose position twice in the same session.

What you must not do with any leftover liquid in the pen

Here is where clarity matters most. Each position in the KwikPen's four-dose cartridge is calibrated individually. Any residual fluid after a dose has been delivered (however much it looks like) is not a bonus dose sitting there waiting. It is a combination of manufacturing overfill, needle-pathway residue and, in some cases, medication that genuinely wasn't delivered if something went wrong with technique.

Attempting to draw on that residual liquid (whether by injecting a second time from the same dose position, by combining it with fluid from another pen or by any other means) is not safe. You have no way of knowing the exact volume remaining, and the pen is not designed to be used that way. The NHS tirzepatide patient information page is clear that each pen should be used as directed and that any unused medicine should be disposed of properly.

For disposal, used pens and detached needles should go into an approved sharps container rather than household bins. If you haven't got one, a 1-litre sharps container is straightforward to keep alongside your pens and is the correct way to handle used equipment.

If you're consistently finding that the window looks unchanged after injections, or you're uncertain whether your doses are landing properly, this is a practical question for your prescriber. It's not a trivial concern, dose consistency matters for how well tirzepatide works. If you notice there's still some Mounjaro left in the pen after your injection, our dedicated page explains what the different scenarios typically mean, and you can also find specific guidance on whether it's safe to use any leftover Mounjaro before deciding how to proceed. You can read more about what different amounts left in a Mounjaro pen usually mean if you want to understand specific scenarios in more detail.

Storage between doses and what it means for the liquid you see

One last detail that sometimes causes confusion: temperature. The KwikPen should be kept refrigerated at 2–8°C between doses. When you take it out of the fridge, you may notice the liquid looks slightly different in the window (occasionally a touch cloudier or with tiny bubbles) compared with when it went in. This is a normal result of the temperature change and, crucially, it can affect how the fluid level appears to the eye.

Always allow the pen to reach room temperature before injecting. Injecting cold medication from the fridge can be uncomfortable and may also affect how smoothly the plunger moves, which in turn changes how much appears to remain afterwards. The exact room-temperature window you can safely leave the pen out for is stated in the patient information leaflet inside your box, refer to that rather than any general estimate, because it is specific to your pen.

If you have questions about storage, technique or anything else about your treatment, the team on our contact page can connect you with aftercare support seven days a week. And if you're still exploring whether Mounjaro is right for you, understanding the cost context alongside the clinical picture is a reasonable place to start before booking a consultation. When you're ready, you can check your eligibility with our prescribers at any time.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions